Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as ‘Lynk Pharmaceuticals’), an innovative clinical stage company, …
Researchers at Fermata to Study SAINT Neuromodulation for Treatment-Resistant Major Depression
Fermata, an outpatient psychiatric center of excellence, today announced a new clinical trial to study …
First Results with Erdafitinib-Releasing Intravesical Delivery System (TAR-210) Show Early Evidence of Positive Clinical Activity in Patients with Non-Muscle-Invasive Bladder Cancer with Select Fibroblast Growth Factor Receptor Alterations
The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the first results from an …
AMGEN PRESENTS NEW LUMAKRAS® (SOTORASIB) PLUS VECTIBIX® (PANITUMUMAB) DATA IN PATIENTS WITH KRAS G12C-MUTATED METASTATIC COLORECTAL CANCER
Amgen (NASDAQ:AMGN) today announced data from the global Phase 3 CodeBreaK 300 trial evaluating two doses …
European Organisation for Research and Treatment of Cancer & the Menarini Group Launch New Clinical Trial in Early-Stage Breast Cancer
The European Organisation for Research and Treatment of Cancer (EORTC) and the Menarini Group (Menarini), …
Kexing Biopharm 2023 Innovation Forum on Targeted Drug Delivery
On September 15, “Kexing Biopharm 2023 Innovation Forum on Targeted Drug Delivery” successfully kicked off. …
Emmes and Essex Management Spark a Clinical Research Evolution with Innovative Bioinformatics
Emmes, a Clinical Research Organization (CRO) with a passion for advancing public health and biopharmaceutical …
